Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene

被引:277
作者
Brogan, IJ [1 ]
Khan, N [1 ]
Isaac, K [1 ]
Hutchinson, JA [1 ]
Pravica, V [1 ]
Hutchinson, IV [1 ]
机构
[1] Univ Manchester, Sch Biol Sci, Immunol Res Grp, Manchester M13 9PT, Lancs, England
关键词
gene polymorphism; promoter; VEGF; 5 ' UTR;
D O I
10.1016/S0198-8859(99)00132-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have characterized 5 novel, single-nucleotide polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor (VEGF) gene. Transitions C --> A at nucleotide position -2578 relative co the translation start sire, T --> C at position -1455, G --> A at position -1154, G --> C at position -1001, and C --> T at position -7 were observed. In addition, individuals with the A allele at position -2578 also had an insertion of 18 nucleotides, whereas CC homozygotes did not contain this insert ion. We have described the frequency distribution of the poly-morphic alleles in the population of healthy volunteers and are investigating the functional significance of the 18-nucleotide insertion and of the single-nucleotide polymorphisms on VEGF gene expression. (C) American Society for Histocompatibility and Immunogenetics, 1999. Published by Elsevier Science Inc.
引用
收藏
页码:1245 / 1249
页数:5
相关论文
共 20 条
  • [1] Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription
    Akiri, G
    Nahari, D
    Finkelstein, Y
    Le, SY
    Elroy-Stein, O
    Levi, BZ
    [J]. ONCOGENE, 1998, 17 (02) : 227 - 236
  • [2] Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation
    Awad, MR
    El-Gamel, A
    Hasleton, P
    Turner, DM
    Sinnott, PJ
    Hutchinson, IV
    [J]. TRANSPLANTATION, 1998, 66 (08) : 1014 - 1020
  • [3] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS
    BERSE, B
    BROWN, LF
    VANDEWATER, L
    DVORAK, HF
    SENGER, DR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220
  • [4] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [5] MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS
    FERRARA, N
    HOUCK, K
    JAKEMAN, L
    LEUNG, DW
    [J]. ENDOCRINE REVIEWS, 1992, 13 (01) : 18 - 32
  • [6] FREEMAN MR, 1995, CANCER RES, V55, P4140
  • [7] HUTCHINSON IV, 1998, GRAFT, V1, P186
  • [8] IIJIMA K, 1992, KIDNEY INT, V42, P1457
  • [9] Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5
  • [10] HYPOXIA REGULATES VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE-EXPRESSION IN ENDOTHELIAL-CELLS - IDENTIFICATION OF A 5'-ENHANCER
    LIU, YX
    COX, SR
    MORITA, T
    KOUREMBANAS, S
    [J]. CIRCULATION RESEARCH, 1995, 77 (03) : 638 - 643